ANN M. HANLY - 29 Nov 2021 Form 4 Insider Report for Vir Biotechnology, Inc. (VIR)

Role
Chief Technology Officer
Signature
/s/ Howard Horn, Attorney-in-Fact
Issuer symbol
VIR
Transactions as of
29 Nov 2021
Net transactions value
+$500
Form type
4
Filing time
01 Dec 2021, 19:20:02 UTC
Next filing
24 Feb 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction VIR Common Stock Purchase $500 +12 $43.39 12 29 Nov 2021 See footnote F1
holding VIR Common Stock 30,600 29 Nov 2021 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The purchase was effectuated by a minor through a trading account registered in the name of the reporting person's spouse.
F2 Includes 600 shares of common stock acquired by the reporting person on November 30, 2021 pursuant to an employee stock purchase program.